OBJECTIVES: The aim of this study was to evaluate outcomes in our department after surgery for obstructive hypertrophic cardiomyopathy and to establish the impact of a delay on the indication for surgery.
INTRODUCTION
Hypertrophic cardiomyopathy (HCM) is a complex and heterogeneous genetic cardiac disease with a prevalence in the adult general population of about 0.2% (1 in 500) [1] . The natural history of the disease is variable, with most patients remaining asymptomatic or with mild symptoms. With a stable and benign clinical course, less invasive treatments are dictated. However, the clinical course can also be adverse, with increased risk of malignant arrhythmias and sudden death, progressive congestive heart symptoms and other related complications despite optimal pharmacological treatment [2] [3] [4] [5] . Left ventricular outflow tract (LVOT) obstruction has been described as an important predictor of morbidity and mortality in patients with HCM [6] .
Surgical septal myectomy has shown to be the most effective, immediate and lasting of the approaches in reduction of intraventricular gradient in patients with HCM and LVOT obstruction [2, 5, 7] . However, the number of patients recruited for such an invasive treatment is small, comprising only those patients with progressive heart failure symptoms, in New York Heart Association (NYHA) functional classes III and IV, refractory to maximal medical therapy, and with the presence of a marked LVOT gradient during resting and/or provocation conditions ( peak instantaneous pressure gradient ≥50 mmHg) [2, 5] .
The aim of this study was to determine, in our patient population, the benefit of surgical treatment (in terms of survival and clinical improvement) when performed before reaching the current criteria for surgical indication established in the 2011 ACCF/AHA Guidelines [5] in comparison to patients operated on in an advanced functional class.
MATERIALS AND METHODS

Study population
Over a 13-year period (between September 1998 and February 2011), 77 consecutive adult patients underwent video-assisted widened septal myectomy in a single centre. We included in our study 69 cases, with diagnosis of HCM previously established by echocardiographic criteria (septal thickness of at least 13 mm), in the absence of a secondary cause of hypertrophy [5, 8, 9] , and with the presence of a dynamic LVOT peak gradient at rest of ≥50 mmHg, with the condition of being followed up for at least 1 year after surgery. Patients with aortic valve stenosis were excluded.
The timing of the indication for surgery was established based on the presence of symptoms despite optimal pharmacological treatment, concomitant significant mitral regurgitation (MR), or on patients, who consented to surgery due to an unacceptable level of symptoms, despite the level of pharmacological adjustment, after the provision of detailed information regarding the benefits, risks and possible complications of surgery.
Surgical procedures
All surgical procedures were performed under cardiopulmonary bypass, with mild hypothermia (30°C), cardioplegic arrest of the heart and left ventricular (LV) venting through the right superior pulmonary vein. We used anterograde and retrograde cold intermittent blood cardioplegia (Cardi-Braun ® ; B-Braun, Inc., Barcelona, Spain) for myocardial protection. An endoventricular approach was taken through a transverse aortotomy 10-15 mm above the sinotubular junction. After exploration of the aortic valve, we put a 5-0 polypropylene stitch into each Arancio node and exteriorized them through the aortic wall in order to take the leaflets apart, to improve exposure and avoid damaging them. With a rigid videoscope of 7-mm diameter with optical angulation of 30°(Telecam SL II-Xenon nova ® ; KARL-STORZ GbmH & Co., Tuttlingen, Germany), we approached the endocavity morphology before proceeding with septal myectomy. Myectomy was commenced with a scalpel as far away as possible from the nadir of the right coronary leaflet, a high-risk region for heart blockage, to avoid heat injury to the conduction system. Blunt dissection of the fibrotic endocardial layer over the place of contact with the anterior mitral leaflet (due to systolic anterior movement) was possible in most patients. Afterwards, we continued with progressive resection of small pieces of muscle of 1-2 mm thickness using a 10 mm × 10 mm bipolar electrocautery handle (LLETZ ® electrode handle; Valleylab-Tyco Healthcare, Gosport, UK). Resection was started in the basal anteroseptal segment, continued through the basal anterior and basal anterolateral segments and descended through the midventricular segments towards the apex. It was especially important to perform a partial myectomy around the anterolateral papillary muscle insertion on the lateral LV free wall, in order to enhance its mobility and reduce anterior tethering of the mitral valve and the midventricular gradients ( Figure 1 ). If any abnormal chordae insertion existed, this was also corrected. When required, a concomitant procedure was performed.
Intraoperative transoesophageal echocardiography was performed by an expert cardiologist in order to determine the absence of a significant LVOT gradient, residual systolic anterior movement, mitral or aortic regurgitation or an iatrogenic ventricular septal defect. If an MR greater than grade III was observed, another aortic cross-clamping period was started in order to repair or replace the mitral valve.
Follow-up
In the first week after surgery, a transthoracic echocardiography study was performed, including measurements of the myocardial wall thickness and cardiac chambers, as in previously published studies [10, 11] . In 2002, cardiac magnetic resonance was introduced in our centre, making it possible to include images of late gadolinium enhancement for risk evaluation [12, 13] in our protocol.
Postoperative follow-up was carried out by direct interviews with the patient at 3 and 12 months (±1.5 months) after surgery and, thereafter, annually with echocardiographic control.
Statistics
We retrospectively analysed data collected in a speciallydesigned database with FileMaker Pro Advanced © version 11.0 Software (FileMaker, Inc., Santa Clara, CA, USA). Statistical analysis was performed with STATA © statistical package version 10 (StataCorp, College Station, TX, USA).
Continuous data was expressed as means ± SD, while for categorical variables we used percentages and absolute values. Differences between the two groups were compared with the χ 2 test or Fisher's exact test for categorical variables, when necessary; for continuous data we used Student's paired t-test, or the Mann-Whitney U-test if a normal distribution was not present. To detect intra-individual differences between preoperative and postoperative values in continuous variables, Student's paired t-test was used, or the Wilcoxon test for nonparametric data. Kolmogorov-Smirnov-Lilliefors test was used to define a normal distribution in continuous data, and Levene's test for assessing equality of variances. Estimates of long-term survival were made with the Kaplan-Meier method, and differences in survival between the two groups ( patients who went to surgery in NYHA class I or II vs those in NYHA class III or IV) were assessed by the log-rank test. A value of P < 0.05 was considered statistically significant when comparing differences.
A multivariate model was performed with logistic regression; individual predictors of mortality with a significance level P ≤ 0.10 were entered step by step into the model. A composite end-point of in-hospital mortality and major postoperative complications (low cardiac output syndrome with requirement for an intraortic balloon pump or implantation of a circulatory support device, acute renal failure requiring haemodialysis, more than 24 h of mechanical ventilation, reoperation for bleeding, deep wound infection and major neurological injury) was presented to maximize statistical power. The Hosmer-Lemeshow goodness-of-fit test was used to select the best model.
Ethics
The Ethical Committee of Hospital Universitari i Politècnic La Fe approved this study, and consent was obtained from all patients.
RESULTS
Baseline characteristics and early results
Extended septal myectomy alone was performed in 59 patients (85.5%). The concomitant surgery required was coronary artery bypass grafting in three cases, procedures on the aortic valve in four (three patients had symptomatic aortic regurgitation concomitant to an HCM, and one patient had a papillary fibroelastoma of the aortic valve), and mitral valve repair or replacement in three. The mean age of the patients was 58 ± 13.7 years (range 19-80 years), and women comprised 56.5% of the study population. Forty-six (66.7%) of the patients displayed an advanced functional class (NYHA class III or IV) before surgery, with a significant difference between genders (79.5% in women vs 50% in men; P = 0.01), while angina was severe in only 15 of them (21.7%). Preoperative mean thickness of the interventricular septum was 21.8 ± 5.2 mm and resting LVOT dynamic peak gradient was 83.9 ± 27.3 mmHg. The diameter of the left atrium (LA) was 42.9 ± 9.1 mm. Preoperative atrial fibrillation was present in 14 cases (20.1%), corresponding to patients with larger LA diameters (51.1 ± 7.4 vs. 41.6 ± 8.7 mm; P = 0.008), without any statistical relation to the magnitude of LVOT obstruction or ventricular septal thickness. Previous septal alcohol ablation had been performed in five cases (7.2%), a pacemaker was implanted before surgery in 10 patients (14.5%) and only one (1.4%) had an implantable cardioverter defibrillator (ICD) as primary prevention of sudden death. Other general data are summarized in Table 1 .
The mean reduction in thickness registered at 3 months after surgery was 8.2 ± 5.8 mm (P < 0.001), corresponding to a reduction in intraventricular peak gradient of 72.2 ± 37.3 mmHg (P = < 0.001).
The reduction in posterior wall thickness was 1.1 ± 2.9 mm, although we did not resect those segments (P = 0.017). No significant changes were observed in left ventricular end-diastolic diameter (P = 0.847), whereas left ventricular end-systolic diameter was increased by 2.1 ± 6.6 mm (P = 0.05). Further details can be found in Table 2 .
Significant MR previous to surgery was present in 27 (39.1%) of the patients (16 cases had a moderate MR and 11 a severe MR), but only five (7.2%) of the patients showed a moderate MR in the early postoperative period.
In-hospital mortality of patients who underwent isolated myectomy was 1.44%, whereas for patients who underwent combined procedures the mortality rose to 4.35%. The only case of death in the isolated myectomy group was due to a haemorrhagic cerebrovascular accident on the 4th postoperative day in a 48-year-old woman. In the combined procedures group, there were three cases of death; the first one was a 44-year-old man who required a mechanical mitral valve replacement as a result of valve repair failure at the first attempt, who died as result of early endocarditis; the second was a 41-year-old woman who needed concomitant aortic valve replacement for non-reparable aortic insufficiency, who died 48 h after surgery due to refractory cardiogenic shock; and the last was a 78-year-old man, who underwent concomitant mitral valve repair, developed mediastinitis complicated with multiple organ failure and died 4 months after surgery.
The most frequent early complication was the onset of atrial fibrillation, which occurred in 17 patients (24.6%). Renal insufficiency developed in nine cases (13%), defined as a doubling of the preoperative serum creatinine value or a decrease of >50% in the calculated glomerular filtration rate, and two patients (2.9%) developed severe acute renal failure that required dialysis. In three cases, a permanent pacemaker was implanted because of postoperative high-grade atrioventricular blockage. Other early postoperative complications are summarized in Table 3 .
Chronic renal insufficiency (P = 0.004), failure of valve repair with the need for a second period of myocardial ischaemia (P = 0.001), and the presence of re-exploration for bleeding, prolonged ventilator support or mediastinitis as a postoperative complication were established as predictors of in-hospital mortality in the univariate analysis. However, for NYHA functional class III or IV, the performance of a concomitant procedure, cardiopulmonary bypass time and aortic cross-clamping time, the level of significance was not reached.
None of these variables had a significant effect in multivariate analysis to be considered as an independent predictor of in-hospital mortality (see Table 4 ). However, for the composite end-point of in-hospital mortality and/or any major postoperative complication, the performance of a combined procedure adjusted for age, sex and chronic renal failure, was found to be an independent predictor (odds ratio 10.4; 95% confidence interval 2.27-47.56; P = 0.003).
Long-term results
The mean follow-up duration was 26.4 ± 19.2 months (range 1 day to 6.25 years). At 1 year, 93.9% of cases presented NYHA class I or II symptoms (P < 0.0001), as well as an improvement of the angina (P = 0.001) if compared with preoperative status. The LVOT gradient at rest and the thickness of the interventricular septum remained stable when compared with early postoperative echocardiographic data, whereas posterior wall thickness underwent an additional reduction with respect to the early postoperative period of 1 mm (SD 2.17; P = 0.017). Neither significant changes in ventricular diameters nor significant changes in the cardiac function parameters were observed compared with the early postoperative period. Moderate MR in the early postoperative period remained stable at the patients' last echocardiographic assessment during follow-up. Only one case of new asymptomatic severe MR was reported at 1 year follow-up.
Two late patient deaths were reported (2.9%), both of which were attributed to cardiac events (congestive heart failure); one of them had previous coronary artery disease. In these two patients, no recurrence of echocardiographic findings was registered in their last echocardiographic assessment. None of the patients suffered any of the following events: sudden cardiac death; ventricular arrhythmias registered in Holter monitoring on follow-up; or new ICD implantation or appropriate defibrillator interventions in those patients with an ICD implanted preoperatively.
For Kaplan-Meier overall postmyectomy survival analysis, we stratified the study population into two groups by functional class: equal to or less than NYHA class II, and equal to or greater than NYHA class III. Compared with the advanced functional class group, the group with lower functional class had better outcomes; the 5-year survival rate was 100% in NYHA classes I and II, and the 1-, 3-and 5-year survival rates in the advanced functional class group were 93.1 ± 1,3, 89.1 ± 2.1 and 83.1 ± 3.7%, respectively. By log-rank test, a trend to a difference between the two groups was shown, but without reaching the level of significance (P = 0.085; Figure 2) .
None of the variables analysed was found to be a significant independent predictor for overall mortality on multivariable analysis.
DISCUSSION
Since W.P. Cleland performed the first myectomy in the early 1960s [14] , more than 50 years of experience endorse the results of the surgical approach for left ventricular outflow tract obstruction in hypertrophic cardiomyopathy [15] . Nevertheless, the classic technique has been improved over recent years, with the development of extracorporeal circulation, myocardial preservation and intraoperative echocardiographic guidance of the procedure [7] . Given the appearance of experienced centres treating large numbers of cases, perioperative mortality has decreased from ≥5% to about 1%, with a very low rate of complications Values are given as n (%). P values are derived from univariate analysis for prediction of in-hospital mortality (*P < 0.05).
[ [16] [17] [18] [19] [20] [21] [22] . Despite these good results, however, surgical treatment is still considered by many groups as the final treatment option, sometimes without powerful arguments. Perhaps, the controversy about this disease, well known until the 1980s, when LVOT obstruction was questioned as the pathophysiological mechanism of the intraventricular dynamic gradient, had an influence in skewing the patterns of patient referral to surgical myectomy, which is a proven, low-risk approach for patients with symptoms that are refractory despite pharmacological treatment [14] . In 2005, Ommem et al. published their results from a cohort of 289 patients with LVOT obstruction who underwent surgical myectomy at the Mayo Clinic [17] . Perioperative mortality was 0.8%, and referral overall survival rates were 98, 96 and 83% at 1, 5 and 10 years, respectively, which is significantly higher than for the group with a non-surgical strategy, and with a long-term survival equivalent to that of the US general population. They established the association of myectomy, male gender, younger age, lower NYHA functional class (11% of patients operated) and absence of AF and coronary disease with improved survival [17] . In the same year, Woo et al. published the results of their experience over more than 25 years at the Toronto General Hospital, in a study population of 338 patients with obstructive HCM recruited for septal myectomy, 89 of whom where submitted to concomitant operative procedures [16] . Early mortality was 0.8% in the group treated by myectomy alone, whereas if combined surgery was performed the mortality increased to 3.4%, with equivalent results in long-term survival. It was in this study that we found a larger group of patients in a lower functional class (28% were in NYHA class I or II); furthermore, Woo et al. showed the importance of parameters such as left atrial diameter and preoperative AF as predictors of survival, suggesting the need to consider a lower threshold for surgery in patients with some predictors of mortality, even if they had no severe symptoms [16] .
In comparison to the published data, the patients in our cohort had slightly higher rates of mortality for isolated myectomy as well as for the combined procedures. However, this is likely to be due to the small study population and the initial effect of the learning curve, because no perioperative deaths have occurred after the initial 30 cases. Observations concerning our results on relief of the LVOT gradient and interventricular septum reduction after myectomy are consistent with other studies, proving the efficacy of this technique in our centre. A progressive reduction in myocardial hypertrophy secondary to LVOT obstruction could be achieved by reducing the LVOT gradient, so that myocardial work decreases. In the same way, the posterior ventricular wall became progressively thinner and, associated with the other ventricular morphological changes, this would be an indirect sign of LV mass regression and remodelling after myectomy.
Although we could not make a comparison with the conventional technique, introduction of a videoscope to assist with the surgical procedure allowed us better visibility of the ventricular chamber, making myectomy easier, safer and possible to be extended towards sites that were difficult to view in some cases, as well as allowing the whole surgical team to see the procedure, which was very important for teaching. Clinical results were also excellent, even slightly better than published, showing an improvement in the functional capacity and symptomatology (disabling or not) that has an effect on quality of life.
As Maron et al. identified, LVOT obstruction has prognostic implications for the clinical progression of the disease (relative risk 4.4), risk of sudden death (relative risk 2.1) and cardiovascular cause of death (relative risk 1.6) [6] . They also suggested that, in selected cases, taking into consideration the implication of the grade of obstruction for survival, an earlier timing of invasive treatment (usually surgery) may be warranted; moreover, this may be warranted if there had been marked obstruction to LV outflow for a long time, even if no symptoms had developed [6] .
Although our study hypothesis was not confirmed, because there was no significant evidence that earlier surgical treatment decreased overall mortality, a tendency (P = 0.085) was found if we compared this group with patients operated on in an advanced functional class. It is likely that enlarging the sample size of the study would yield significance. It must be highlighted that the absence of ventricular arrhythmias on ambulatory (Holter) ECG recordings, new ICD placements or ICD-sensed and aborted ventricular tachyarrhythmia in patients with a previously implanted ICD in our study cohort might confer to a protective effect of gradient reduction in the origin of these electrophysiological alterations. In some studies, the incidence of lifethreatening ventricular arrhythmias after myectomy was 0.2-0.9% per year, which was lower than in patients with an untreated obstruction [23] . Nevertheless, no definitive evidence is available in the published data to demonstrate that myectomy is a protective factor in lowering the risk of ventricular arrhythmias; therefore, studies specifically designed for this purpose are needed.
LIMITATIONS
This is a retrospective, mainly descriptive, single-centre study, so there are important limitations in the results and in the validity of this data set. Firstly, given that there was no medical arm for comparison in the design of our study, we cannot prove that early myectomy is better than medical therapy in terms of survival. However, the objective of this report is to expose an observed phenomenon in our cohort of patients that, nevertheless, would need an extended and specifically design study in a larger patient cohort for clarification, so as to avoid possible bias and confusion factors. Given that sample size remains limited, this cohort is heterogeneous, which reduces the power to detect significant differences between groups, so we have observed only non-significant trends in patterns of behaviour in variables. Perhaps the small sample is also the reason why we have not found, in our cohort, the left atrium size, the presence of preoperative AF or other parameters previously described as being related to survival. Also, despite the fact that our group is a referral centre in our area, it is a centre with a low number of patients, which may have an adverse influence on our results. Finally, we have not included in the analysis the cardiac magnetic resonance data, which would have provided further information on the changes after myectomy, because missing data could affect our results.
Therefore, the results here reported are only a modest description from a single centre with real working conditions, without the patient selection that centres of expertise could have, requesting on-going research.
CONCLUSIONS
In conclusion, surgical treatment by means of widened septal myectomy for hypertrophic cardiomyopathy has been proven to provide an effective approach for amelioration of outflow obstruction and symptomatology, for both severe and mild symptoms, with a low risk in specialized centres once the learning curve is overcome. This might be translated into an increase in survival, probably greater in patients with mild or moderate symptoms. Even so, most of the patients are referred as candidates for surgery when severe maximal drug-refractory symptoms have developed or when a surgical indication is established by a concomitant cardiac disease, worsening the results. Nevertheless, additional and specifically designed studies are required to determine whether early surgical treatment has real implications for survival and the risk of developing complications (e.g. disease progression, ventricular arrhythmias, cerebrovascular accidents), because its efficacy for control of symptoms seems to be more clearly established.
APPENDIX. CONFERENCE DISCUSSION
Dr C. Simon (Bergamo, Italy): I would like to ask about NYHA functional class II. Looking at the guidelines, we now know that, normally, patients in NYHA functional classes III and IV who are unresponsive to maximal medical treatment will receive a septal myectomy. So do you think that perhaps some studies, some multicentre studies, can be useful to extend the indication also to patients in NYHA functional class II?
My other question is about the septal myectomy. Do you usually tailor it according to the thickness of the interventricular septum of the patients, or do you always perform it the same regardless of the thickness of it? We know that normally hypertrophic cardiomyopathy is related to mitral valve incompetence. Do you perform any manoeuvre on the subvalvular apparatus?
Dr Cambra: Well, our experience is not so extensive as the series from the Mayo Clinic or the Toronto General Hospital who have published around 300 patients in their reports. But we think that patients in advanced NYHA functional class have higher mortalities, as is also seen with other types of surgery. In our study, no deaths at follow-up were related to the less symptomatic patients. Only the presence of functional class II is associated with higher overall mortality at follow-up in the literature. This is one of the end points in the paper from Maron and colleagues; they describe a 10% annual rate of evolution to functional class III or IV only with the onset of symptoms, not limiting symptoms, before the patient develops heart failure symptoms. For these reasons we think that in functional class II, the risk of evolution at one year follow-up is too high.
Referring to the technique, we try to achieve an interventricular septum thickness around 13 mm. Of course, the majority of patients do not need any additional procedure to the mitral valve in spite of the significance of their mitral regurgitation, because we try to extend the myectomy to the apex and liberate the papillary muscles to avoid restriction of the movement of the mitral valve apparatus that is sometimes associated with the hypertrophic cardiomyopathy.
Dr R. Lorusso (Brescia, Italy): I have a question. You mentioned electrocautery. You said that sometimes you use it, if this is correct. Do you always use it to finish your resection? You showed the video at the end of the procedure.
Dr Cambra: We always make a myectomy with a scalpel near the nadir of the noncoronary sinus to avoid the heat injury of the conduction system, while the rest of the myectomy, extended myectomy, is made with an electrocautery hand-held resector. This is the same sort of resector that could be used in a prostatectomy.
Dr Lorusso: Would you elaborate a little bit more on that? I mean, do you have a specific indication or do you use it in all the cases?
Dr Cambra: We use it in all cases.
